SU1220562A3 - Способ получени концентрированных гидрозолей,содержащих липофильные и гидрофильные витамины - Google Patents

Способ получени концентрированных гидрозолей,содержащих липофильные и гидрофильные витамины Download PDF

Info

Publication number
SU1220562A3
SU1220562A3 SU833599272A SU3599272A SU1220562A3 SU 1220562 A3 SU1220562 A3 SU 1220562A3 SU 833599272 A SU833599272 A SU 833599272A SU 3599272 A SU3599272 A SU 3599272A SU 1220562 A3 SU1220562 A3 SU 1220562A3
Authority
SU
USSR - Soviet Union
Prior art keywords
vitamin
vitamins
hydrosols
glycerin
solution
Prior art date
Application number
SU833599272A
Other languages
English (en)
Russian (ru)
Inventor
Такачи Надь Геза
Коватш Иштван
Тот Арпад
Лазар Андреа
Шорш Агнеш
Хуташ Иштван
Original Assignee
Рихтер Гедеон Ведьесети Дьяр Рт. (Инопредприятие)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Рихтер Гедеон Ведьесети Дьяр Рт. (Инопредприятие) filed Critical Рихтер Гедеон Ведьесети Дьяр Рт. (Инопредприятие)
Application granted granted Critical
Publication of SU1220562A3 publication Critical patent/SU1220562A3/ru
Priority to LV930677A priority Critical patent/LV5398A3/xx
Priority to LTRP752A priority patent/LT2281B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SU833599272A 1982-05-21 1983-05-20 Способ получени концентрированных гидрозолей,содержащих липофильные и гидрофильные витамины SU1220562A3 (ru)

Priority Applications (2)

Application Number Priority Date Filing Date Title
LV930677A LV5398A3 (lv) 1982-05-21 1993-06-28 Lipofilus un hidrofilus vitaminus saturosu koncentretu hidrosolu iegusanas panemiens
LTRP752A LT2281B (lt) 1982-05-21 1993-07-01 Koncentrotu hidrozoliu turinciu lipofilinius ir hidrofilinius vitaminus, gavimo budas

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU163282A HU185533B (en) 1982-05-21 1982-05-21 Process for producing concentrated hydrosoles containing h lipophilic and hydrophilic vitamines

Publications (1)

Publication Number Publication Date
SU1220562A3 true SU1220562A3 (ru) 1986-03-23

Family

ID=10955423

Family Applications (1)

Application Number Title Priority Date Filing Date
SU833599272A SU1220562A3 (ru) 1982-05-21 1983-05-20 Способ получени концентрированных гидрозолей,содержащих липофильные и гидрофильные витамины

Country Status (8)

Country Link
AT (1) AT384548B (cg-RX-API-DMAC10.html)
BE (1) BE896782A (cg-RX-API-DMAC10.html)
CA (1) CA1204385A (cg-RX-API-DMAC10.html)
DD (1) DD209734A5 (cg-RX-API-DMAC10.html)
DE (1) DE3318513A1 (cg-RX-API-DMAC10.html)
GB (1) GB2120939B (cg-RX-API-DMAC10.html)
HU (1) HU185533B (cg-RX-API-DMAC10.html)
SU (1) SU1220562A3 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3053408B2 (ja) 1989-02-28 2000-06-19 日清製粉株式会社 安定化された油溶性ビタミン含有組成物
JP2822058B2 (ja) 1989-05-29 1998-11-05 ゼリア新薬工業株式会社 安定な点眼剤
DE4242876C2 (de) † 1992-12-18 1997-11-27 Beiersdorf Ag Kosmetische und/oder dermatologische Zubereitungen zur kosmetischen und/oder dermatologischen Pflege der Haut und/oder der Hautanhangsgebilde
JP2990686B2 (ja) * 1994-11-17 1999-12-13 田辺製薬株式会社 水溶性ビタミンb類配合総合輸液

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD27938A (cg-RX-API-DMAC10.html) *
DD36799A (cg-RX-API-DMAC10.html) *
US2417299A (en) * 1943-08-06 1947-03-11 Us Vitamin Corp Fat-soluble vitamin solutions
US2907696A (en) * 1956-01-03 1959-10-06 Pfizer & Co C Stable vitamin a for aqueous dispersions
FR1372408A (fr) * 1960-06-15 1964-09-18 Ile De Rech S Scient Et Ind So Procédé de fabrication de solutions et émulsions polyvitaminées aqueuses stablesà l'air et à la lumière
US3070499A (en) * 1960-09-19 1962-12-25 Merck & Co Inc Parenteral aqueous solutions of fat soluble vitamins
CH437995A (de) * 1963-11-01 1967-06-15 Hoffmann La Roche Verfahren zur Gewinnung von lipophile Substanzen enthaltenden Präparaten
AU2629871A (en) * 1970-03-17 1972-09-14 Merck & Co., Inc Solubilization of water and aqueous solutions in non-aqueous liquids
DE2050630A1 (de) * 1970-10-15 1972-05-31 Farbwerke Hoechst AG vormals Meister Lucius & Brüning, 6000 Frankfurt Arzneimittellösung
DE2526938C2 (de) * 1975-02-14 1982-04-22 F. Hoffmann-La Roche & Co. AG, 4002 Basel Vitaminpräparate

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Патент US № 4159326, кл. 424-236, 1979, Патент US № 2417299, кл. 424-237, 1947. *

Also Published As

Publication number Publication date
CA1204385A (en) 1986-05-13
ATA185783A (de) 1987-05-15
DE3318513C2 (cg-RX-API-DMAC10.html) 1993-07-01
GB8313969D0 (en) 1983-06-29
DD209734A5 (de) 1984-05-23
AT384548B (de) 1987-11-25
DE3318513A1 (de) 1983-11-24
HU185533B (en) 1985-02-28
GB2120939B (en) 1986-01-22
GB2120939A (en) 1983-12-14
BE896782A (fr) 1983-09-16

Similar Documents

Publication Publication Date Title
CN101686924B (zh) 辅酶q10的纳米乳液组合物
EP0499399B1 (en) Analgesic compositions
EP0665000B1 (fr) Composition hydratante pour le traitement simultané des couches superficielles et profondes de la peau, son utilisation
US6299889B1 (en) Stable ascorbic acid preparation for topical use
EP2968138B1 (en) Racecadotril lipid compositions
FI112777B (fi) Valmistusmenetelmä antivirus-aktiiviselle farmaseuttiselle öljy-vedessä emulsiolle, jossa on 9-[(2-hydroksietoksi)-metyyli]-guaniini (asyklovir) tai sen suola tai esteri
JPH06509577A (ja) W/oミクロエマルジョン
US4927638A (en) Etoposide solutions
DD300404A5 (de) Pharmazeutische zubereitung
EP2649993A1 (en) Stabilizer of acetaminophen
EP0010437B1 (en) Stable erythromycin solution and process therefor
US9687430B2 (en) Cosmetic kit comprising effervescent tablet and skin toner
Rees et al. The dissolution of salicylic acid in micellar solutions of polysorbate 20
AU611461B2 (en) Controlled release of antibiotic salts from an implant
JPH0717498B2 (ja) 鎮咳去痰ソフトカプセル剤
JPH06247853A (ja) 安定なビタミンa類及びビタミンe類可溶化点眼剤
CN120753976A (zh) 一种含重组胶原蛋白的油溶性组合物及其制备方法
Rowe et al. In vitro protection of amphibian gastric mucosa by nutrient HCO3− against aspirin injury
JPH0892102A (ja) ビスホスホン酸又はその誘導体を含有する注射液とその安定化方法、及び注射液アンプル
Kang et al. Preparation and characterization of two-phase melt systems of lidocaine
Kivilaakso Contribution of ambient HCO3-to mucosal protection and intracellular pH in isolated amphibian gastric mucosa
JP3313148B2 (ja) 皮膚外用剤
JPH0725735A (ja) 含嗽剤
JP3192234B2 (ja) 皮膚外用剤
Malonne et al. In vitro/in vivo characterization of a tramadol HCl depot system composed of monoolein and water